A few studies, conducted in high-incidence areas, have reported that genetic polymorphisms of TLR3, TLR4, TLR9, and TLR10 are associated with a risk of developing NPC in endemic populations [19–22], but outcome results related to TLR expression are lacking worldwide. This evidence concerns the gene TLR9 and nasopharyngeal carcinoma.